Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone.
about
The albumin-exendin-4 recombinant protein E2HSA improves glycemic control and β-cell function in spontaneous diabetic KKAy mice.Glycemic Control in a Real-Life Setting in Patients with Type 2 Diabetes Treated with IDegLira at a Single Swiss Center.The Clinical Use of a Fixed-Dose Combination of Insulin Degludec and Liraglutide (Xultophy 100/3.6) for the Treatment of Type 2 Diabetes.Insulin degludec + liraglutide: a complementary combination.Insulin Degludec/Liraglutide.
P2860
Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Type 2 Diabetes Patients Reach ...... ec or Liraglutide Given Alone.
@ast
Type 2 Diabetes Patients Reach ...... ec or Liraglutide Given Alone.
@en
type
label
Type 2 Diabetes Patients Reach ...... ec or Liraglutide Given Alone.
@ast
Type 2 Diabetes Patients Reach ...... ec or Liraglutide Given Alone.
@en
prefLabel
Type 2 Diabetes Patients Reach ...... ec or Liraglutide Given Alone.
@ast
Type 2 Diabetes Patients Reach ...... ec or Liraglutide Given Alone.
@en
P2093
P2860
P1476
Type 2 Diabetes Patients Reach ...... ec or Liraglutide Given Alone.
@en
P2093
Henrik Jarlov
Jiten Vora
Kajsa Kvist
Lawrence Blonde
P2860
P304
P356
10.1007/S40261-016-0376-0
P577
2016-02-19T00:00:00Z